Anticonvulsants in bipolar disorder.

@article{Singh2005AnticonvulsantsIB,
  title={Anticonvulsants in bipolar disorder.},
  author={Vivek Singh and David J. Muzina and Joseph R. Calabrese},
  journal={The Psychiatric clinics of North America},
  year={2005},
  volume={28 2},
  pages={
          301-23
        }
}
In recent years, a number of anticonvulsants have been more rigorously investigated for their potential mood-stabilizing properties. They are heterogeneous in their mechanisms of action and in their efficacy in the various mood states in bipolar illness (Table 3). At present, evidence from well-controlled studies supports the role of DIV and CBZ in the treatment of acute mania. DIV seems to have better efficacy than lithium in mixed mania or mania associated with depressive symptoms and is… Expand

Topics from this paper

The role of lamotrigine in the management of bipolar disorder
TLDR
It would seem prudent to await greater evidence of efficacy before designating lamotrigine as first-line treatment for other bipolar indications, as the strongest evidence for its efficacy lies in the prevention of bipolar depression. Expand
Mood stabilizers for patients with bipolar disorder: the state of the art
TLDR
An updated review of the available literature in relation to the role of mood stabilizers in bipolar disorder, with particular emphasis on their mechanism of action, main clinical aspects and specific use in the different phases of BD treatment, according to the most recently published international treatment guidelines. Expand
Safety and tolerability of anticonvulsant medication in bipolar disorder
TLDR
Whereas both valproate and carbamazepine are associated with, in part, severe adverse events, lamotrigine emerges as a relatively safe and well tolerated treatment option, especially in maintenance treatment and prevention of depressive relapse in BD. Expand
Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence
TLDR
The mechanisms underlying LTG’s anti-manic properties remain to be fully explored, but the available pre-clinical evidence points out to the role of glutamatergic neurotransmission, possibly through AMPA-receptors. Expand
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.
TLDR
Low-dose aspirin produced a statistically significant duration-independent reduction in the relative risk of clinical deterioration in subjects on lithium, whereas other NSAIDs and glucocorticoids did not. Expand
Encephalopathy Associated with Psychotropic Drug Therapy
TLDR
In this chapter, the author provides a comprehensive overview of the abovementioned adverse effects affecting the CNS function associated with psychotropic pharmacotherapy. Expand
Why are antiepileptic drugs used for nonepileptic conditions?
TLDR
The future design of new AEDs must also include a potential in nonepileptic CNS disorders, such as bipolar disorder and neuropathic pain, where the global market size is similar to that of epilepsy, whereas they both currently have fewer approved drugs for treatment than epilepsy. Expand
Anticonvulsants in bipolar disorder
  • H. Grunze
  • Psychology, Medicine
  • Journal of mental health
  • 2010
TLDR
Understanding the mechanisms of action and identifying similarities between anticonvulsants effective in bipolar disorder may also enhance the understanding of the underlying pathophysiology of the disorder. Expand
Drug safety evaluation of zonisamide for the treatment of epilepsy
Introduction: Zonisamide is a broad spectrum antiepileptic drug with multiple mechanisms of action which has been recently approved in the US and Europe as an adjunctive therapy for refractoryExpand
Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
  • V. Hamrin, Maryellen C Pachler
  • Psychology, Medicine
  • Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc
  • 2007
TLDR
Screening of youth with mood spectrum problems for bipolar disorder should occur in every diagnostic assessment and should be ongoing due to range of mood symptoms and the cyclical and episodic nature of this disorder. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 77 REFERENCES
New Anticonvulsant Medication Uses in Bipolar Disorder
TLDR
Emerging evidence suggests lamotrigine may have utility in bipolar disorder patients with depression and treatment-refractory rapid cycling, as well as analgesic effects, which may still offer important new options in relieving a variety of specific target symptoms in patients with bipolar disorder. Expand
Lamotrigine in the treatment of bipolar disorder
  • C. Bowden
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2002
Lamotrigine has undergone a remarkable series of systematic studies since 1994 that now establish it as an efficacious, well-tolerated treatment in bipolar disorder. Its efficacy principallyExpand
Antidepressant Properties of Anticonvulsant Drugs for Bipolar Disorder
TLDR
Current evidence concerning the acute and prophylactic efficacy of divalproex, carbamazepine, gabapentin, lamotrigine, and topiramate in bipolar depression is evaluated and findings in placebo-controlled trials suggest an acute and anti-doping effect with lamotigine monotherapy and more modest antidepressant benefits with other agents administered as monotherapies. Expand
Treatment of Mood Disorders with Antiepileptic Medications: Clinical and Theoretical Implications
TLDR
Clinical studies and reviews of at least one anticonvulsant, carbamazepine, suggest that many patients may experience positive effects on mood and behavior while being treated for their seizure disorders with this agent, although this remains controversial. Expand
Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression
TLDR
Dival Proex improved several dimensions of depressive morbidity and reduced the probability of depressive relapse in bipolar disorder, particularly in patients who had responded to divalproex when manic, and among patients with a more severe course of illness. Expand
Monotherapy treatment of bipolar disorder with levetiracetam
  • K. Kaufman
  • Medicine, Psychology
  • Epilepsy & Behavior
  • 2004
TLDR
A patient with treatment-resistant rapid cycling bipolar disorder who failed 15 psychotropics, individually or in various combinations, but ultimately responded to levetiracetam monotherapy and remained without bipolar features during 1 year of maintenance treatment, excluding 1 week during which the patient was medicine noncompliant. Expand
Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.
TLDR
There is a need for randomised controlled trials examining the efficacy and acceptability of tiagabine in the acute treatment of bipolar disorder, after the nature of these episodes has been clarified. Expand
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
TLDR
Topiramate appears to show promise as an addition to the agents available to treat bipolar disorder as well as for the prophylaxis either as monotherapy or as combination treatment. Expand
A review of randomized, controlled clinical trials in acute mania.
TLDR
This review considers the evidence supporting the use of somatic therapies (medications and electroconvulsive therapy) in the treatment of acute mania associated with bipolar disorder and preliminary data suggest that some calcium channel blockers and several anticonvulsants, e.g., lamotrigine, gabapentin, and topiramate, may have therapeutic value. Expand
A double- Blind placebo-controlled study of lamotriqine monotherapy outpatients with bipolar I depression
TLDR
Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar I depression and demonstrates significant antidepressant efficacy on the 17-item Hamilton Rating Scale for Depression and MADRS compared with placebo. Expand
...
1
2
3
4
5
...